OS Therapies Incorporated (OSTX)
Healthcare
Biotechnology
1.60 $
+2.0%
vs. previous close
Closing price · As of: 3. Aug 2026
OS Therapies Incorporated (OSTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -4.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.8 | -0.9 | -0.9 | -0.6 | -0.9 | -3.4 | -2.4 | -3.4 | -2.4 | -4.7 | -3.7 | -4.6 | -15 | |
| 0.8 | 0.0 | 0.2 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.1 | 0.1 | 363 | 0.1 | 363 | |
| – | – | – | 0.0 | 0.0 | 0.0 | – | 0.9 | 0.9 | 0.8 | 4,263 | 1.4 | 4,266 | |
| 0.0 | 0.1 | 0.4 | 0.2 | 0.2 | -0.8 | 0.3 | -0.3 | 1.5 | 1.0 | 6.9 | 3.9 | 13 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 0.5 | 0.5 | 0.0 | 1.2 | |
| 0.0 | – | 0.0 | – | – | – | – | -0.2 | -0.3 | -466 | -466 | – | – | |
| – | – | – | – | – | – | – | – | – | 6,398 | 6,398 | – | – | |
| – | – | – | – | – | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 1.8 | |
| 0.5 | 0.8 | 0.9 | 0.7 | 0.9 | 5.1 | 6.1 | 1.1 | 2.5 | 3.8 | 2.1 | 5.2 | 14 | |
| -0.3 | 0.0 | 0.0 | 0.1 | 0.0 | 1.8 | 3.7 | -2.6 | -0.2 | -0.9 | -1.6 | 0.6 | -2.1 | |
| -0.8 | -0.9 | -0.9 | -0.6 | -0.9 | -3.4 | -2.4 | -3.6 | -2.7 | -4.7 | -3.7 | -4.6 | -16 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.